Skwirczyńska E

ORCID: 0000-0003-1946-748X · 3 papers in corpus
2023
Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy.
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13030452

HE4 is a commonly used tumor marker for ovarian cancer (OC) diagnosis. In our study, we aimed to assess its use in the diagnosis of subsequent OC recurrences and to evaluate its changes during recurrence diagnosis and the subsequent lines o…

2023
Psychological Associations of Stress with the Level of Health Locus of Control and Self-Efficacy in Patients with Ovarian Cancer.
Journal of clinical medicine ·doi:10.3390/jcm12216816

The aim of this study was to analyze the locus of health control, self-efficacy and stress coping styles of female patients treated for ovarian cancer. Learning the styles of coping with stress in patients with ovarian cancer may contribute…

2022
Evaluation of the Influence of Biological Factors during the Course of Treatment in Patients with Ovarian Cancer.
International journal of environmental research and public health ·doi:10.3390/ijerph191710516

The aim of this study was to evaluate the influence of β-endorphins and serotonin on the course of treatment, disease-free time, and overall survival of patients with ovarian cancer. This study may contribute to the identification of modifi…